Lotus Financial Statements From 2010 to 2024
| LTUS Stock | USD 0.0008 0 75.76% |
Check Lotus Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lotus Pharmaceuticals' main balance sheet or income statement drivers, such as , as well as many indicators such as . Lotus financial statements analysis is a perfect complement when working with Lotus Pharmaceuticals Valuation or Volatility modules.
Lotus |
Lotus Pharmaceuticals Company Return On Asset Analysis
Lotus Pharmaceuticals' Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Lotus Pharmaceuticals Return On Asset | 0.0456 |
Most of Lotus Pharmaceuticals' fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Lotus Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Lotus Pharmaceuticals has a Return On Asset of 0.0456. This is 109.7% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 132.57% lower than that of the firm.
Lotus Pharmaceuticals Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lotus Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Lotus Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lotus Pharmaceuticals competition to find correlations between indicators driving Lotus Pharmaceuticals's intrinsic value. More Info.Lotus Pharmaceuticals is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 2.51 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lotus Pharmaceuticals' earnings, one of the primary drivers of an investment's value.About Lotus Pharmaceuticals Financial Statements
Lotus Pharmaceuticals shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Lotus Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Lotus Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Lotus Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the Peoples Republic of China. Lotus Pharmaceutical operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 233 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Lotus Pink Sheet Analysis
When running Lotus Pharmaceuticals' price analysis, check to measure Lotus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceuticals is operating at the current time. Most of Lotus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lotus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.